SCHEDULE: Vanguard Group Amends QuidelOrtho Stake, Reports 11.52% Beneficial Ownership

The Vanguard Group has filed an Amendment No. 5 to its Schedule 13G, disclosing a beneficial ownership of 11.52% in QuidelOrtho Corp's Common Stock as of June 30, 2025.

Summary

• The Vanguard Group, based in Malvern, PA, is the reporting person for this Schedule 13G Amendment No. 5.
• The filing pertains to Common Stock of QuidelOrtho Corp, with CUSIP Number 219798105, located at 9975 Summers Ridge Rd, San Diego, CA, 92121.
• As of June 30, 2025, The Vanguard Group beneficially owns an aggregate of 7,796,462 shares of QuidelOrtho Corp's Common Stock.
• This aggregate amount represents 11.52% of the class of securities.
• The Vanguard Group holds 0.00 shares with sole voting power and 84,476.00 shares with shared voting power.
• The group holds 7,628,449.00 shares with sole dispositive power and 168,013.00 shares with shared dispositive power.
• The Vanguard Group is classified as an Investment Adviser (IA) under Rule 13d-1(b)(1)(ii)(E).
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership by a large institutional investor, providing no direct positive or negative operational or financial news about the issuer.

Positives

• The Vanguard Group, a prominent institutional investor, maintains a significant 11.52% stake in QuidelOrtho Corp, indicating a substantial long-term investment by a major fund manager.

Future Outlook

NA

Management Comments

• The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by a major institutional investor like The Vanguard Group may be viewed as a vote of confidence in QuidelOrtho Corp, potentially reassuring existing shareholders and attracting new ones.

Key Dates

Keywords

QuidelOrtho Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Adviser